Demographic and pregnancy characteristics are depicted in Table 1. Maternal age, body mass index, history of PTB as well as medical risk factors for PTB were comparable between the two groups. The rate of nulliparity was significantly higher in women in the twins group compared with singleton gestation, and within the twins group most women conceived with ovulation induction/ intrauterine insemination whereas in the singleton group most women conceived spontaneously.
Table 1
Comparison between twins and singleton gestation
a. Patient characteristics
|
Twins
(n = 16)
|
Singletons
(n = 100)
|
p value
|
Age, years
|
31.2 ± 5.8
|
34.2 ± 6.1
|
.07
|
Nulliparous
|
13 (81.3)
|
56 (56.0)
|
.04
|
Pre-pregnancy BMI, kg/m2
|
22.03 (20.6–25.2)
|
22.27 (19.8–26.7)
|
.90
|
Hx of PTB
|
12.5 (2)
|
25.0 (25)
|
.30
|
Medical risk factors for PTB1
|
81.3 (13)
|
73.0 (73)
|
.70
|
Present pregnancy
|
|
|
|
Mode of conception
Spontaneous
Ovulation induction/ IUI
IVF/ ED
|
2 (3.1)
3 (33.3)
11 (25.6)
|
62 (96.9)
6 (66.7)
32 (74.4)
|
.001
|
GDM
GDMA1
GDMA2
|
1 (6.3)
0
|
16 (16.0)
6 (6.0)
|
.47
|
Hypertensive disorders of pregnancy2
|
0
|
2 (2.0)
|
1.00
|
Intrahepatic cholestasis of pregnancy
|
0
|
1 (1.0)
|
1.00
|
b. Cerclage Characteristics
|
|
|
|
GA at cerclage placement, weeks
|
20.85 (18.6–22.8)
|
20.85 (18.6–22.8)
|
.90
|
Presence of cervical dilation
|
8 (50.0)
|
40 (40.0)
|
.40
|
Cervical length, mm
|
11.5 (7.2–14)
|
14 (7.2–20.7)
|
.10
|
Bulging membranes
|
7 (43.8)
|
34 (34.0)
|
.40
|
Indication for cerclage
Short cervical length
Dilation and/ or bulging membrane
|
8 (50.0)
8 (50.0)
|
54 (54.0)
46 (46.0)
|
.70
|
Sludge
|
2 (12.5)
|
16 (16.0)
|
1.0
|
Funneling
|
11 (68.8)
|
51 (51.0)
|
.10
|
Cerclage type
McDonald
Shirodkar
|
3 (18.8)
13 (81.3)
|
17 (17.3)
81 (82.7)
|
1.00
|
Progesterone treatment before cerclage
|
7 (43.8)
|
50 (50.0)
|
.60
|
Progesterone treatment after cerclage
|
12 (75)
|
77 (77.0)
|
1.00
|
Amniocentesis before cerclage
|
1 (6.3)
|
19 (19.0)
|
.30
|
c. Perinatal Outcome
|
|
|
|
Alive newborn deliveries ≥ 24 weeks
|
11 (62)
|
89 (89)
|
.045
|
Time interval from cerclage to delivery, weeks
|
14.1 (6.2–16.2)
|
16.3 (10.8–18.6)
|
.10
|
GA at delivery, weeks
|
36.1 (25.3–37.2)
|
37.7 (32.5–38.9)
|
.02
|
< 24 weeks
|
4 (25)
|
11 (11)
|
.132
|
< 28 weeks
|
4 (25.0)
|
20 (20.0)
|
.70
|
< 32 weeks
|
6 (37.5)
|
24 (24.0)
|
.35
|
< 37 weeks
|
10 (62.5)
|
43 (43.0)
|
.10
|
Mode of delivery
|
|
|
|
Vaginal
|
5 (31.3)
|
68 (68.0)
|
0.01
|
Cesarean
|
5 (31.3)
|
25 (25.0)
|
0.56
|
Operative vaginal
|
5 (31.3)
|
4 (4.0)
|
0.002
|
Abortion (D&E)
|
1 (6.3)
|
3 (3.0)
|
0.45
|
PPROM
|
3 (18.8)
|
19 (19.0)
|
1.00
|
Chorioamnionitis
|
4 (25.0)
|
14 (14.0)
|
.27
|
Termination of pregnancy
|
2 (12.5)
|
8 (8.0)
|
.60
|
Fetal death
|
1 (6.3)
|
1 (1.0)
|
.25
|
d. Neonatal outcomes4
|
n = 115
|
n = 896
|
|
Gender
Male
Female
|
6 (54.5)
5 (45.5)
|
44 (49.5)
45 (50.5)
|
.70
|
Birth weight, g
|
2615 (2100–2788)
|
2965 (2403–3290)
|
.03
|
Weight percentile
|
76.0 (52.0–82.0)
|
51.0 (31.0–71.0)
|
.10
|
Apgar 1
|
9.0 (8.0–9.0)
|
9.0 (9.0–9.0)
|
.07
|
Apgar 5
|
10.0 (9.0–10.0)
|
9.0 (8.0–9.0)
|
.10
|
pH Cord
|
7.22 ± .087
|
7.26 ± .059
|
.20
|
NICU7
|
3 (27.2)
|
17 (19.1)
|
.525
|
Mechanical ventilation
|
1
|
8
|
|
Death during 1st month of life
|
0
|
1 (1.1)
|
1.00
|
Days in hospital
|
6 (4–25)
|
4 (4-7.5)
|
.30
|
Composite neonatal complications3
|
3 (27.2)
|
17 (19.1)
|
.525
|
Values are presented as median (IQR) or n (%)
BMI – body mass index, PTB – preterm birth, IUI – intrauterine insemination, IVF – in vitro fertilization, ED – egg donation, GDM – gestational diabetes mellitus, GA – gestational age, PPROM – preterm premature rupture of membranes, NICU – Neonatal intensive care unit.
1Positive history of any of the following: D&E, cervical preparation, conization, hysteroscopy, uterine anomaly, chronic hypertension, smoking.
2 Pregnancy induced hypertension, preeclampsia or HELLP syndrome.
3 Composite adverse neonatal outcome included one or more of the following: NICU admission, mechanical ventilation, neonatal mortality.
4 Neonatal outcomes are reported for alive born deliveries from 24 weeks of gestation
5 Excluded (n = 5):
6 Excluded (n = 11):
Chorioamnionitis at < 24 weeks (n = 7), of which 1 case with IUFD. 2 had sPTL, the rest underwent labor induction or D&E.
Table 1 describes cerclage characteristics in the two groups. The rate of indications for cerclage (short cervix indicated by transvaginal ultrasound vs cervical dilation by physical examination) did not differ significantly between the two groups. A comparison between the time interval from cerclage to delivery by indications for cerclage between and within groups was performed (Table 2).
Table 2
Time interval from cerclage to delivery by cerclage indication
|
Twins
|
p value
|
Singletons
|
p value
|
|
Cervical dilation
(n = 8)
|
Cervical shortening
(n = 8)
|
|
Cervical dilation
(n = 40)
|
Cervical shortening
(n = 60)
|
|
Time interval from cerclage to delivery, weeks
|
8.0 ± 6.4
|
15.4 ± 4.6
|
0.025
|
12.1 ± 7.4
|
15.9 ± 5.2
|
0.007
|
|
Twins (n = 8)
|
Singletons (n = 40)
|
|
Twins (n = 8)
|
Singletons (n = 60)
|
|
|
Cervical dilation
|
|
Cervical shortening
|
|
Time interval from cerclage to delivery, weeks
|
8.0 ± 6.4
|
12.1 ± 7.4
|
0.153
|
15.4 ± 4.6
|
15.9 ± 5.2
|
0.803
|
Values are presented as mean ± standard deviation.
Results show that among singleton and twin gestations, the time interval was significantly prolonged in cases of cervical shortening versus cervical dilation, and there was no significant difference between the two groups when compared by cerclage indications. Other variants including the rate of cases in which amniocentesis was performed prior to the procedure, gestational age at cerclage placement and the mean cervical length measured by transvaginal ultrasound were similar between the two groups. Similarly, the presence of cervical dilatation, bulging membranes, sludge, and funneling were also comparable between the two groups. The majority of patients underwent Shirodkar cerclage technique. The use of intravaginal progesterone application (either Utrogestan 200 mg twice daily or Crinone 8%, 1 application daily) before and after cerclage placement did not differ between groups. Six patients in the singletons group underwent repeated cerclage, whereas no repeated cerclage was performed in the twins group. The indication for a second cerclage was either progressive cervical dilatation or bulging membranes.
Delivery and neonatal outcomes are presented in Table 1. The time interval from cerclage placement to delivery did not differ between twins and singleton gestations (14.1 weeks (IQR 6.2–16.2) vs 16.3 weeks (IQR 10.8–18.6), respectively, p = .11). As expected, women with twin gestations delivered earlier compared to women with singletons (36.1 weeks (IQR 25.3–37.2) vs 37.7 weeks (IQR 32.5–38.9), p = .02), but the rates of PTB prior to 24, 28, 32, and 37 weeks did not differ between the two groups. Similarly, there was no difference in the rate of PPROM, chorioamnionitis, termination of pregnancy and fetal demise between the groups. Eleven (62%) twin pregnancies and 89 (89%) singleton pregnancies ended with alive newborn (p = .045). Four (25%) cases of the twin group and 11 (11%) cases of the singleton group (p = .132) delivered prior to 24th weeks of gestation due to spontaneous preterm labor (one case of twins, 2 singletons), or underwent induction of labor or D&E due to chorioamnionitis (three twins and seven singletons) and PPROM (four singletons). As expected, the mean birth weight was significantly lower in the twin group compared to the singleton group (2615 g, (IQR 2100–2788) vs. 2965 g (IQR 2403–3290), p = .037). However, weight percentiles did not differ between the groups. Apgar scores, umbilical cord pH, length of hospitalization and the rate of neonatal intensive care unit admission, as well as mechanical ventilation use, neonatal mortality, and the rate of the composite adverse neonatal outcome were similar between the two groups.
Multivariate regression analysis (Table 3) revealed that cervical dilation at the time of cerclage placement was the only factor independently associated with increased risk for PTB < 32 weeks of gestation (Odds ratio [OR], 3.63; 95% confidence internal 1.02–12.85), while twin gestation was not associated with increased risk for PTB < 32 weeks (OR, 1.68; 95% confidence interval .49- 5.77).
Table 3
Multivariate analysis of factors associated with preterm birth < 32 weeks
Variable
|
OR (95% CI)
|
p value
|
Twin gestation
|
1.683 (.490- 5.779)
|
.40
|
Gestational age at time of cerclage placement
|
.882 (.741 − 1.050)
|
.10
|
Cervical dilation
|
3.630 (1.025–12.855)
|
.04
|
Bulging membranes
|
2.308 (.714-7.455)
|
.10
|
Adjustment was made for maternal age, pre-gestational body mass index and parity. |